|
||||||||||||||||||
Feature Article Quality Assurance, Research,
and Everything In Between Mary Banks RN, BS, BSN Educational Objectives: At the end of this activity, participants should be able to:
According to 45 CFR 46. 102(f) in the federal regulations, human subject means a living individual about whom an investigator (whether professional or student) conducting research obtains:
These
regulations go on to state that intervention includes
both physical procedures by which data are gathered (for example, venipuncture),
and manipulations of the subject or the subject's environment that are performed
for research purposes. The regulations state that interaction
“includes communication or interpersonal contact between investigator
and subject” (in person, by mail, telephone, email, etc.). It should
be noted that these definitions are purposefully broad enough to include
humans involved in social behavioral--as well as biomedical--research.
Based on the definition above, an investigator may assume that he/she has human subjects if he/she collects private, identifiable information about people for research even if he/she does not intervene or interact with them. Private information includes information about behavior that occurs in a context in which an individual can reasonably expect that no observation or recording is taking place; and that the information he/she has provided for specific purposes will not be made public (for example, a medical record). Information is individually identifiable if the identity of the subject is or may readily be ascertained by the investigator. Information is also individually identifiable if the individual can be associated with the information (i.e., the information does not contain any direct identifiers, but the person’s identity can still be ascertained through deductive disclosure from the data that is collected).
According to 45 CFR 46 102(d), research means a systematic investigation (including research development, testing and evaluation) designed to develop or contribute to generalizable knowledge. In a recent presentation for PRIMR (Public Responsibility in Medicine and Research) on April 22, 2008, Jeffrey M. Cohen, PhD, CIP (President, HRP Associates, Inc.), defined systematic investigation as “an activity that involves a prospective research plan which incorporates data collection, either quantitative or qualitative, and data analysis to answer a research question”. Investigators may have heard that “designed to contribute to generalizable
knowledge” means only that the results will be published or presented
at a scientific meeting. While these activities do represent a contribution
to generalizable knowledge, they represent only part of the
Quality assurance (QA) or Quality Improvement (QI) are like human subjects research but do not specifically meet the definition of human subjects research. The federal regulations under 45 CFR 46 do not provide a specific definition for quality assurance (QA). In his presentation, Cohen defined QA as “a systematic collection and analysis of information about the effectiveness of a program in order to make judgments about the program, improve program effectiveness, and/or inform decisions about future program development.” It is sometimes called “program evaluation.” QA involves gathering information from or about human beings. QA/ QI activities are usually undertaken to assess the effectiveness of a specific program, practice or service. QA/QI projects that do not involve human subjects research do NOT require IRB review. This does not mean that there are not ethical concerns related to QA/QI projects, just that these concerns are addressed by institutions in various ways other than by IRB review. For more information about these issues please see Why We Need Ethical Oversight of Quality Improvement Projects, Editorial, Thomas V. Perneger, International Journal for Quality in Health Care, 2004, Vol. 16: 343-344, Number 5.
Quality assurance, human subjects research or both? The following table may assist investigators in differentiating between
QA and human subjects research activities. In the end, however, the IRB
has the final responsibility for determining whether projects meet the
definition of human subjects research.
Example of a problem with a study that involved QA and Research In July
of 2007, OHRP sent a determination letter to Johns Hopkins regarding
the following study: Peter
Pronovost, et. al. An Intervention to Decrease Catheter-Related Bloodstream
Infections in the ICU. New England Journal of Medicine 2006; 355: 2725-2732.
This study was not reviewed by the Hopkins IRB under the 45
CFR 46 regulations because they had determined the project to be QA
rather than human subjects As these letters indicate, the OHRP expects institutions who hold a FWA, to carefully review projects to determine whether or not they meet the definitions of human subjects research and, therefore, are subject to IRB approval and compliance with the regulations under 45 CFR 46. These OHRP determination letters precipitated a great deal of discussion in the research community. Subsequently, several editorials were written on this topic of QA versus research. These discussions emphasize the fact that distinguishing between quality assurance and human subjects research is sometimes not easy. “A Lifesaving Checklist”, Dr. Atul Gawande, an Op-Ed Contributor to the New York Times; December 30, 2007. “Pointy-Headed Regulation”, New York Times Editorial Staff Response to “A Lifesaving Checklist”, Editorials, New York Times; January 27, 2008. “Quality-Improvement Research and Informed Consent”, Franklin G. Miller, Ph.D., and Ezekiel J. Emanuel, M.D., Ph.D. , The New England Journal of Medicine, February 21,2008, (Volume 358:765-767, Number 8). “Harming through Protection?”, Mary Ann Baily, Ph.D., The New England Journal of Medicine, February 21, 2008, (Volume 358:768-768, Number 8).
BUMC institutional policy and procedures Here at BUMC, any projects that MAY meet the definition of human subjects research must be submitted to the BUMC IRB for an initial review and determination. To obtain this initial IRB review, projects are submitted to the IRB via INSPIR as Exempt applications. For Exempt projects, only a limited number of sections on the INSPIR application need to be completed. Please click here for instructions for completing the INSPIR application for Exempt review. A project that is determined to be NOT human subjects research will receive
A project that is determined to be human subjects research MAY be determined to be Exempt under one of the Federally designated Exempt categories. A letter will then be generated via INSPIR indicating that the project is exempt from further IRB review as long as no changes are made to the protocol. If a project is determined to be nonexempt human subjects research, then it will need additional IRB review as either an expedited or full board study. The principal investigator will be notified via a letter (modification memo) generated through INSPIR of the IRB’s determination. (Note: If the IRB determines that the study is NOT exempt, additional information will need to be added to the protocol prior to Expedited or Full Board review by the IRB. This will be explained in the INSPIR modification memo.)
All activities that meet the regulatory definition of human subjects research must be reviewed by the IRB. All nonexempt human subjects research must have IRB approval and must comply with the regulations under 45 CFR 46. Most quality assurance activities are NOT human subjects research and, therefore, do not fall under the 45 CFR 46 requirements. However, if any portion of a QA project might be human subjects research, then the project must be submitted to the IRB for review and a determination. Quiz This Quiz applies to the recertification period from July 1, 2007 to June 30, 2009. CME credits are no longer offered or available as of 9/15/2010. Click
here and close window if you are a BUMC researcher |
||||||||||||||||||